Paolo Francesco Fabene Selected Research

Paolo Francesco Fabene Research Topics

5	Status Epilepticus (Complex Partial Status Epilepticus) 12/2022 - 10/2007
5	Seizures (Absence Seizure) 12/2022 - 06/2009
3	Epilepsy (Aura) 12/2022 - 06/2009
2	Stroke (Strokes) 01/2020 - 01/2017
1	Anosmia 01/2022
1	Constipation 01/2022
1	Neuroinflammatory Diseases 01/2021
1	Neuroacanthocytosis 01/2021
1	Ischemia 01/2020
1	Multiple Sclerosis 06/2015
1	Adjustment Disorders (Adjustment Disorder) 06/2015
1	Sleep Deprivation 03/2013
1	Hypoxia (Hypoxemia) 03/2013
1	Alzheimer Disease (Alzheimer's Disease) 03/2013
1	Temporal Lobe Epilepsy 06/2009
1	Wounds and Injuries (Trauma) 10/2007

5	Pilocarpine (Ocusert)FDA LinkGeneric 12/2022 - 10/2007
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2020
1	ConnexinsIBA 12/2022
1	Proto-Oncogene Proteins c-relIBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2021
1	nilotinib FDA Link 01/2021
1	tau Proteins (tau Protein)IBA 01/2021
1	SynucleinsIBA 01/2021
1	gamma-Aminobutyric Acid (GABA)IBA 01/2020
1	Leukotriene B4IBA 01/2020
1	Dinoprostone (PGE2)FDA Link 01/2020
1	LeukotrienesIBA 01/2020
1	Glutamic Acid (Glutamate)FDA Link 01/2020
1	Endothelin-1 (Endothelin 1)IBA 01/2020
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2017
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2017
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2017
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2017
1	Pentylenetetrazole (Metrazol)IBA 01/2017
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2017
1	Fingolimod Hydrochloride (FTY720)FDA Link 06/2015
1	Antidepressive Agents (Antidepressants)IBA 06/2015
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 06/2015
1	Histone Deacetylases (Histone Deacetylase)IBA 06/2015
1	cupric sulfide (CuS)IBA 06/2015

1	Neurological Rehabilitation 01/2020
1	Transcranial Magnetic Stimulation 03/2013